JEFFREY MYATT: Open Payments
NPI 1679850465 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 24 payments from 14 companies in 2025. Trend: 2023 $517 · 2024 $1,225 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $170 |
| HEARTFLOW, INC. | 2 | $98 |
| BIOTRONIK INC. | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| AtriCure, Inc. | 2 | $47 |
| SCPHARMACEUTICALS INC. | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Novo Nordisk Inc | 2 | $41 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $32 |
Products named: Kerendia, FFRct, AMVUTTRA, AMVIA EDGE, ATRICLIP LAA EXCLUSION SYSTEM, FUROSCIX, LEQVIO, Wegovy.
Industry payments across NV — which companies pay providers there.
